Acyclovir and Dexlansoprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Dexlansoprazole (dexlansoprazole). Common drug interactions include epistaxis among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Dexlansoprazole. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Dexlansoprazole?

Dexlansoprazole has active ingredients of dexlansoprazole. eHealthMe is studying from 3,192 Dexlansoprazole users. Check the latest studies of Dexlansoprazole.

On Jul, 26, 2026

28 people who take Acyclovir and Dexlansoprazole together, and have interactions are studied.

Acyclovir and Dexlansoprazole drug interactions.

What are the common drug interactions of Acyclovir and Dexlansoprazole, by gender? *:

female:

Epistaxis (bleed from the nose)
Gastritis (inflammation of stomach)
Hypertension (high blood pressure)
Immune system disorder
Immunosuppressant drug level increased
Injection site reaction
Inner ear inflammation
Intervertebral disc compression (spinal disc compression)
Intervertebral disc protrusion (spinal disc protrusion)
Liver injury

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Intervertebral disc space narrowing (spinal disc space narrowing)
Lumbar vertebral fracture
Mobility decreased (ability to move is reduced)
Multiple fractures
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Partner stress

What are the common drug interactions of Acyclovir and Dexlansoprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anxiety
Arthralgia (joint pain)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Depression
Fatigue (feeling of tiredness)
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Malignant neoplasm progression (cancer tumour came back)
Pelvic venous thrombosis (blood clot occurring inside a blood vessel and thromboses (dvts) that form in the deep veins of the legs or in the pelvic veins)

50-59:

Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Partner stress
Sacroiliitis (an inflammation of the sacroiliac joint)
Shoulder operation
Spinal compression fracture (fracture due to spinal compression on bone)
Spinal osteoarthritis (joint cartilage loss in spine)
Vertebral foraminal stenosis (narrowing of the intervertebral foramen)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

60+:

Headache (pain in head)
Abdominal pain
Aortic valve incompetence
Aphonia (inability to produce voice)
Aspartate aminotransferase increased
Back pain
Blood albumin decreased
Blood alkaline phosphatase increased
Blood calcium decreased
Blood fibrinogen decreased

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 25.00%
Multiple Myeloma (cancer of the plasma cells): 5 people, 17.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 17.86%
Infection: 4 people, 14.29%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 14.29%
Nausea (feeling of having an urge to vomit): 3 people, 10.71%
Hiv Infection: 2 people, 7.14%
Blood Potassium Decreased: 2 people, 7.14%
Constipation: 2 people, 7.14%
Depression: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Dexlansoprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously